Post by Biocartis
47,700 followers
๐๐ข๐๐ก ๐ข๐จ๐ฅ ๐๐ฅ๐๐ ๐ช๐๐๐๐ก๐๐ฅ: ๐๐ฅ๐ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐ถ๐ป ๐ฎ๐ฌ๐ฎ๐ฒ: ๐ช๐ต๐ฎ๐'๐ ๐ก๐ฒ๐, ๐ช๐ต๐ฎ๐'๐ ๐ก๐ฒ๐ ๐? ๐๐ป ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ถ๐๐'๐ ๐ฃ๐ฒ๐ฟ๐๐ฝ๐ฒ๐ฐ๐๐ถ๐๐ฒ ๐ผ๐ป ๐๐ถ๐ผ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐ Thursday 25 June, 13:00 (CEST) ๐ค Professor Jenny Seligmann (Consultant Medical Oncologist, Leeds Teaching Hospitals NHS Trust & Professor of Gastrointestinal Oncology, University of Leeds) ๐ Online, registration required ๐๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐: - The key changes in ESMO mCRC guidelines - The role of dual IHC/molecular testing for immunotherapy eligibility - The emerging testing strategies in early-stage disease ๐ ๐ฆ๐ฎ๐๐ฒ ๐๐ผ๐๐ฟ ๐๐ฝ๐ผ๐ ๐ป๐ผ๐: https://lnkd.in/eCACjXx3 Canโt join live? By registering, you will get access to the recording afterwards. #Biocartis #Idylla #CRC #mCRC #Oncology #BiomarkerTesting #ESMO